Showing results (301-310 of 323) with videos related to

Sort By:
Pageof 33
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2026
Osimertinib Plus Gefitinib in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer and EGFR (C797X) Mutation Following First-Line Osimertinib: ORCHARDSarah B Goldberg, Myung-Ju Ahn, Christina Baik, et al.
Translational Lung Cancer Research|April 15, 2026
Molecular and clinical disparity of EGFR-mutant non-small cell lung cancer (NSCLC) based on histopathological stage and EGFR molecular subtypesDayoung Yoon, Ji Won Lee, Byoung Chul Cho, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 5, 2019
Immunogenicity of Influenza Vaccination in Patients with Cancer Receiving Immune Checkpoint InhibitorsBhumsuk Keam, Chang Kyung Kang, Kang Il Jun, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
VEGFR2 blockade overcomes acquired KRAS G12D inhibitor resistance driven by PI3Kγ activationSung-Hyun Hwang, Mingyun Bae, Ji-Won Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2023
Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR- or ALK-Mutated Non-Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04)Sehhoon Park, Tae Min Kim, Ji-Youn Han, et al.
Cancer Research and Treatment|June 16, 2026
Perceptions and Use of Complementary and Alternative Medicine among Patients with Cancer and Their Family Members (KCSG PC21-19)Young-Woong Won, Sun Young Rha, Jung Hye Kwon, et al.
Pageof 33